Literature DB >> 1705207

Developmental expression of proteolipid protein and DM20 mRNAs and proteins in the rat brain.

S M LeVine1, D Wong, W B Macklin.   

Abstract

Proteolipid protein (PLP) and DM20, two abundant proteins of myelin, are produced from alternatively spliced mRNAs from the primary PLP gene transcript. Recent studies on the mouse, bovine and human central nervous systems have found that DM20 protein is expressed prior to PLP during development. As development proceeds, however, PLP becomes the predominant protein. This implies that there must be some form of regulation controlling the ratio of these proteins during development. If this regulation occurs during transcription or splicing, the PLP/DM20 mRNA ratio should mimic the PLP/DM20 protein ratio during development. In order to study these closely related mRNAs, we developed a method that used oligonucleotide probes to specifically identify PLP or DM20 mRNA. In this study, we established that (1) as with other species studied, the DM20 protein is present at higher or equivalent levels to PLP during early rat brain development, and (2) PLP and DM20 mRNAs have essentially identical developmental profiles in the rat, although the DM20 mRNA is expressed at lower levels than PLP mRNA. Since the PLP/DM20 protein ratio in young rats does not reflect the PLP/DM20 mRNA ratio, the mechanism of regulation responsible for altering the PLP/DM20 protein ratio during development must occur after transcription and splicing. Possible posttranscriptional mechanisms controlling the ratio of these proteins during development are discussed.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1705207     DOI: 10.1159/000111853

Source DB:  PubMed          Journal:  Dev Neurosci        ISSN: 0378-5866            Impact factor:   2.984


  21 in total

1.  Expression of proteolipid protein gene in spinal cord stem cells and early oligodendrocyte progenitor cells is dispensable for normal cell migration and myelination.

Authors:  Danielle E Harlow; Katherine E Saul; Cecilia M Culp; Elisa M Vesely; Wendy B Macklin
Journal:  J Neurosci       Date:  2014-01-22       Impact factor: 6.167

2.  Proteolipid promoter activity distinguishes two populations of NG2-positive cells throughout neonatal cortical development.

Authors:  Barbara S Mallon; H Elizabeth Shick; Grahame J Kidd; Wendy B Macklin
Journal:  J Neurosci       Date:  2002-02-01       Impact factor: 6.167

3.  Modeling the Mutational and Phenotypic Landscapes of Pelizaeus-Merzbacher Disease with Human iPSC-Derived Oligodendrocytes.

Authors:  Zachary S Nevin; Daniel C Factor; Robert T Karl; Panagiotis Douvaras; Jeremy Laukka; Martha S Windrem; Steven A Goldman; Valentina Fossati; Grace M Hobson; Paul J Tesar
Journal:  Am J Hum Genet       Date:  2017-03-30       Impact factor: 11.025

4.  Pelizaeus-Merzbacher disease: a valine to phenylalanine point mutation in a putative extracellular loop of myelin proteolipid.

Authors:  D Pham-Dinh; J L Popot; O Boespflug-Tanguy; P Landrieu; J F Deleuze; J Boué; P Jollès; A Dautigny
Journal:  Proc Natl Acad Sci U S A       Date:  1991-09-01       Impact factor: 11.205

5.  Identification of novel mRNAs expressed in oligodendrocytes.

Authors:  H Baba; B Fuss; J B Watson; L T Zane; W B Macklin
Journal:  Neurochem Res       Date:  1994-08       Impact factor: 3.996

6.  Targeted deletion of the antisilencer/enhancer (ASE) element from intron 1 of the myelin proteolipid protein gene (Plp1) in mouse reveals that the element is dispensable for Plp1 expression in brain during development and remyelination.

Authors:  Glauber B Pereira; Fanxue Meng; Neriman T Kockara; Baoli Yang; Patricia A Wight
Journal:  J Neurochem       Date:  2012-12-21       Impact factor: 5.372

7.  Myelin/oligodendrocyte glycoprotein is a member of a subset of the immunoglobulin superfamily encoded within the major histocompatibility complex.

Authors:  D Pham-Dinh; M G Mattei; J L Nussbaum; G Roussel; P Pontarotti; N Roeckel; I H Mather; K Artzt; K F Lindahl; A Dautigny
Journal:  Proc Natl Acad Sci U S A       Date:  1993-09-01       Impact factor: 11.205

8.  Interleukin-6 (IL-6) receptor/IL-6 fusion protein (Hyper IL-6) effects on the neonatal mouse brain: possible role for IL-6 trans-signaling in brain development and functional neurobehavioral outcomes.

Authors:  Susan H Brunssen; Sheryl S Moy; Arrel D Toews; Christopher A McPherson; G Jean Harry
Journal:  Brain Behav Immun       Date:  2012-09-08       Impact factor: 7.217

9.  Oligodendroglial defects during quakingviable cerebellar development.

Authors:  Kenneth R Myers; Guanglu Liu; Yue Feng; James Q Zheng
Journal:  Dev Neurobiol       Date:  2015-12-22       Impact factor: 3.964

Review 10.  The multiple roles of myelin protein genes during the development of the oligodendrocyte.

Authors:  Daniel Fulton; Pablo M Paez; Anthony T Campagnoni
Journal:  ASN Neuro       Date:  2010-02-01       Impact factor: 4.146

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.